Developing an effective accessible vaccine to end tuberculosis worldwide
The Bryson Lab combines immunoengineering, molecular microbiology, synthetic and systems biology to design and develop new therapeutics for infectious diseases and other immunologic disorders.
Infectious diseases remain one of human health's greatest challenges. Our lab is committed to making impact in our understanding of the basic mechanisms of infection pathogenesis in an effort to leverage these basic principles in service of new vaccines and therapeutics.
We are especially interested in the role of the human innate immune system in controlling infection dynamics. We draw from our combined expertise in immune engineering, molecular microbiology, synthetic and systems biology, and computational modeling to accelerate the generation of novel insights about infection.
Presently, our research group is especially focused on Mycobacterium tuberculosis (Mtb) which causes tuberculosis (TB). TB is the leading cause of infectious disease death and one of human history's top ten causes of mortality. More than one million people die every year due to TB, and estimates suggest that 1/4 to 1/3 of the global population has been infected with Mtb.
The Team
We are a collaborative team of scientists who tackle tough problems in immunity with the hope of developing basic insights in service of human translational impact.
Core Member Ragon Institute of Mass General, MIT and Harvard
B.S. Mechanical Engineering, MIT Ph.D. Biological Engineering, MIT Postdoctoral Researcher, Fortune Group, Harvard
Lab Members
We are a team of postdoctoral fellows, graduate students, research staff, and undergraduates. If you are interested in joining our team, please get in touch!
Ragon Institute 600 Main Street Cambridge, MA 02139
Our lab space and offices are located in the brand new Ragon Institute equipped with state of the art microscopy, flow cytometry and BSL3 research facilities.